8th Annual DDR Inhibitors Summit
Exploring emerging targets such as USP1 and WRN – these combined efforts are making DDR inhibitor drug development an increasingly dynamic and transformative area.
Exploring emerging targets such as USP1 and WRN – these combined efforts are making DDR inhibitor drug development an increasingly dynamic and transformative area.
Showcase the latest delivery technologies, data from clinically successful extra-hepatic targeting, cutting-edge AI tools to assist payload design, and breakthrough chemical modifications
With presentations and panel discussions on industry trends and outsourcing challenges, this 2-day event is a must-attend for the European medical device and diagnostics community.
Features all-new insights on building a quality culture, maintaining compliance throughout change management, and securing buy-in and support from executive leadership for your risk planning strategy
Designed to provide attendees with up-to-date, practical information and best practices that can be applied immediately into daily clinical practice
Offers a timely opportunity to explore the latest breakthroughs and emerging trends driving the future of agricultural biotechnology.
MD&M West offers attendees an event experience like no other, delivering the pinnacle in cutting-edge components and technology.
The Pharma Market Research Conference is the key to uncovering knowledge and developing new business relationships.
It showcase the latest innovations in AI integration, novel reimbursement avenues and alternative regulatory pathways to achieve commercial viability.
Liquid biopsy testing has continued to revolutionize diagnostics and personalized medicine; from the integration of AI and automation to elevate liquid biopsy capabilities, to the approval of MRD as an endpoint in Multiple Myeloma.